SMARCA4 and non-small cell lung carcinoma: BRG1-KO in Calu6 (a BRG1-WT NSCLC cell line) significantly increased its sensitivity to multiple drugs, including inhibitors of histone deacetylases (HDACs) and DNA methyltransferases (DNMTs), in vitro.